期刊文献+

纳米粒子在肿瘤成像及治疗中的研究进展 被引量:3

Progress of Nanoparticles in Tumor Image and Treatment
下载PDF
导出
摘要 纳米粒子(20~400 nm)颗粒小,可通过血管的渗透增强和滞留效果而积累在肿瘤细胞中,避免被肾脏所清除,从而使其在血管中有更长的血液循环时间;纳米粒子比表面积大,可以携带大量的化疗药物用于药物的传递;纳米粒子表面经过改造后可以结合不同的靶向基团,并利用共价键结合到细胞表面受体,从而可将药物运输到特定的部位。近年来,越来越多的科研工作者致力于研究纳米颗粒与一些生物分子之间的关系,以此来开发更有效和特异性的抗癌药物。引用了近10年的参考文献,主要介绍了纳米粒子在肿瘤成像及治疗中的应用。 The size of nanoparticles( 20 ~ 400 nm) makes it can accumulate in the tumors by the effect of enhancing permeability and retention effect. It can avoid renal filtration and has a long blood circulation times. In the same time,the surface of nanoparticles is big enough for drug delivery,it can conjugate to different chains after surface modification and conjugate to the surface of tumor by the receptors. Thus,it can transfer the drug to the especial position. In recent years,more and more scientists devote to research the relation between nanoparticles and biomaterials in order to develop more efficient and specificity anti-cancer drug. In this work,an overview of the use of nanoparticles in tumors diagnose and treatment is provided.
出处 《化学试剂》 CAS 北大核心 2016年第4期291-296,共6页 Chemical Reagents
基金 国家自然科学基金资助项目(21101032)
关键词 纳米粒子 表面改造 肿瘤成像和治疗 nanoparticles surface functionalization tumors image and treatment
  • 相关文献

参考文献1

二级参考文献46

  • 1Abruzzese RV, Godin D, Mehta V, et al. Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible Gene Switch system. Mol Ther 2000: 2:276-87.
  • 2Prieto J, Qian C, Sangro B, Melero Ⅰ, Mazzolini G. Biological therapy of liver tumors. Surg Clin North Am 2004; 84:643-57.
  • 3Trinchieri G. Interleukin- 12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70:83-243.
  • 4Caruso M, Pham-Nguyen K, Kwong YL, et al, Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.Proc Natl Acad Sci U S A 1996: 93:11302-6.
  • 5Mazzolini G, Qian C, Xie X, et al. Tumor regression and long-term protection for colon cancer after intratumoral injection of adenovirus expressing IL-12. Cancer Gene Ther 1999; 5:514-22.
  • 6Barajas M, Mazzolini G, Genove G, et al, Gene Therapy of Orthotopic Hepatocellular Carcinoma in Rats Using Adenovirus Coding for interleukin-12 (IL-12). Hepatology 2001; 33:52-61.
  • 7Liu Y, Ehtesham M, Samoto K, et al. In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther 2002: 9:9-15.
  • 8Nasu Y, Bangma CH, Hull GW, et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model Gene Ther 1999: 6:338-49.
  • 9Zhang R, DeGroot LJ. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin- 12. Endocrinology 2003; 144:1393-8.
  • 10Wang L, Hemandez-Aicoceba R, Shankar V, et al. Prolonged and inducible transgene expression in the liver using gutless adenovirus: A potential therapy tbr liver cancer. Gastroenterology 2004; 126: 278-89.

共引文献12

同被引文献4

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部